ReviewDrug safety2015

Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) project.

Katherine C Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.